Saturday, July 11, 2026

pharma · Gastric Cancer · Colorectal Cancer

Ono Pharmaceutical

Ono Pharmaceutical clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Osaka, JP HQ
441 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Osaka, JP
Employees
441
Programs
4
Drugs
2
Patents
0
Intelligence · Clinical Programs

Ono Pharmaceutical projects

1 ClinicalTrials.gov programs sponsored by Ono Pharmaceutical.

Ono Pharmaceutical has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. ONO-4578

    Ono Pharmaceutical Co.,

    Metastatic Pancreatic Cancer

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Ono Pharmaceutical have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.